Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium
Beginning March 4, 2020, infection prevention measures were instituted in the Hospital East-Limburg, a tertiary care center in Belgium, including testing and contact tracing of all symptomatic patients and staff, changes in hospital operations, and provision of personal protective equipment (PPE). After the first case was detected March 13, widespread antibody prevalence was screened for among hospital staff.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium
Introduction for Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Summary for Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Antibody Testing in Germany
Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
Diagnostic Tool for Coronavirus Being Developed by University of Warwick
Saliva could be an alternative fluid to test COVID-19 antibodies
Seroprevalence of anti-SARS-CoV-2 spike protein antibodies in the New York Metropolitan Area